Global Airway Management Devices Market 2025-2035

Description

List of Tables

Global Airway Management Devices Market Size, Share & Trends Analysis By Type (Supraglottic Airway Management Devices, Infraglottic Airway Management Devices, Resuscitators, Laryngoscopes, Others), and by End-Users (Hospitals & Clinics, and Homecare) Forecast Period (2025-2035)

Industry Overview

Airway management devices market was valued at $2,038 million in 2024 and is projected to reach $3,928 billion by 2035, growing at a CAGR of 6.2% from 2025 to 2035. Airway management devices are medical tools that keep the airway open for proper breathing during anesthesia, emergencies, or critical care, preventing obstruction and ensuring ventilation. The government across the globe is expanding healthcare infrastructure by increasing the number of advanced facilities, improving services, and advancing solutions. The expansion of healthcare infrastructure is expected to propel the growth of the market during the forecast period.

In August 2024, North America is modernizing, updating, and expanding healthcare infrastructure across the region. The government has increased funding for healthcare and allocated approximately $1 billion in the American Rescue Plan. Additionally, the state of Texas allocated $11.7 billion for behavioral health. The University of Nebraska Medical Center (UNMC) received approval from its Board of Regents to proceed with planning a $2.19 billion academic medical center in Omaha, and more. Such initiatives will propel the growth of the market during the forecast period.

Market Dynamics

AI Assisted Systems for Airway Management

The integration of AI & robotics is transforming airway management procedures to improve the complex procedures and ensure safer practices. For instance, aiEndoscopic that introduces AI & robotics in Endoscopy for easier and safer procedures. The company provides larynGuide, an AI solution for airway management. The company's larynGuide supports the users to guide them through the procedures. The Laryngoscopy Guide helps users to successfully perform the complex task of laryngoscopy and tracheal intubation. The system works in two stages. First, a trained neural network processes the visual input from the video laryngoscope. Then, an AI interpreter translates the network's output into clear, situation-specific guidance for the clinician.

Growing Prevalence of Respiratory Diseases

The airway management devices market is growing due to the rising prevalence of chronic obstructive pulmonary disease (COPD). The growing prevalence of respiratory diseases is increasing the demand for effective respiratory support and advanced airway management solutions. For instance, according to the World Health Organization (WHO), COPD is the fourth leading cause of death across the globe. COPD affects more than 80 million people globally. The WHO also revealed that approximately. 6.8 million people are newly diagnosed each year. WHO stated that the cases of COPD will rise globally by 23% by 2050. Thus, this rise in respiratory diseases will create the demand for advanced airway management solutions during the forecast period. Additionally, the WHO has included COPD in its Global Action Plan to prevent and Control Noncommunicable Diseases (NCDs).

Market Segmentation

Based on the type, the market is segmented into supraglottic airway management devices, infraglottic airway management devices, resuscitators, laryngoscopes, and others. The supraglottic airway management devices include oropharyngeal airways (OPAS), laryngeal mask airways (LMAs), and nasopharyngeal airways. The infraglottic airway management devices include endotracheal tubes and tracheostomy tubes.
Based on the end-users, the market is segmented into hospitals & clinics and home care.

Supraglottic Airway Management Devices Segment to Lead the Market with the Largest Share

The supraglottic airway management devices segment is expected to hold the largest share of the market due to their widespread adoption in both emergency and elective procedures. The advancement in nasopharyngeal airway devices and innovation by key market players to enhance patient safety is further accelerating market growth. For instance, in June 2024, Applied Medical Technology announced the launch of IntelAir, a nasal airway support system. The company's IntelAir is a single-use device which make sure airway security, avoids cannula migration, and maintains a clear airway.

Hospitals & Clinics: A Key Segment in Market Growth

The rising prevalence of respiratory diseases such as asthma and COPD across the globe is expected to increase the demand for hospitals and clinics. The healthcare systems & government across the globe are expanding hospitals, along with healthcare expenditure is further driving the growth of the market during the forecast period. For instance,

According to the India Brand Equity Foundation (IBEF), in the Union Budget 2025-26, the government has provided $11.50 billion to the healthcare sector for the development, maintenance, and enhancement of the country's healthcare system. This is the 9.78% rise from the earlier allocation of $10.47 billion in FY25.
According to Central Bureau Voor de Statistiek (CBS), in 2024, Healthcare expenditure grew faster than the economy in the Netherlands. The Netherlands spent approximately. $132.5 billion (113.5 billion euros) on healthcare in 2024. The expenditure in 2024 was 8.1% more than in 2023.
In December 2024, the National Health Commission (NHC) announced that they have come together with three other government departments for the establishment of wholly foreign-owned hospitals. The NHC announced the detailed work plan and stated that the hospitals will be established in the nine major cities, including Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and the entire island of Hainan.

Regional Outlook

The global airway management devices market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

Advanced Healthcare Infrastructure & Innovation in North America is Driving the Market Growth

The presence of advanced healthcare infrastructure in the region is expected to propel the growth of the market during the forecast period. The continuous product innovation and strategic initiatives by the market players, particularly in video laryngoscopes and advanced infraglottic devices, are further driving the market. For instance, in January 2025, Ambu announced the launch of its new video laryngoscopy solution to facilitate efficient intubation in both routine and difficult airway procedures in the operating room (OR) and intensive care unit (ICU). Ambu initiated the launch of the Ambu SureSight Connect solution in the USA.

Asia-Pacific Region Shares Significant Market Share

The Asia-Pacific region is witnessing the fastest growth in the airway management devices market due to the growing number of patients suffering from chronic respiratory conditions. For instance, in 2024, the article published on The Lancet Respiratory Medicine, India currently has 33 million patients with asthma and 55 million patients with chronic obstructive pulmonary disease (COPD).

Market Players Outlook

The global airway management devices market is led by companies such as Fisher & Paykel Healthcare Ltd., Cook Group, Inc., Cardinal Health Inc., Boston Scientific Corp., Becton Dickinson and Co., Armstrong Medical Ltd., Ambu A/S, Medtronic PLC, Teleflex Inc., and ICU Medical, Inc., among others with market players driving growth through strategic partnerships, collaborations, mergers, and acquisitions, continuous product innovations, advanced technology integration, and expansion into emerging markets to strengthen their market presence.

Recent Developments

In October 2024, Verathon launched a laryngoscope made with bio-based plastics. These are the first single-use video laryngoscopes designed to demonstrate excellence in patient care and can coexist with care for their environment.
In May 2023, SunMed announced that they have completed the acquisition of the Respiratory & Anesthesia Consumables Business of Vyaire Medical. Through this merger, the company will lead the airway and operative care manufacturer, offering practitioners a comprehensive range of high-quality respiratory and anesthesia products for optimal patient outcomes.

The Report Covers:

Market value data analysis for 2024 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global airway management devices market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2022568

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Airway Management Devices Market Sales Analysis - Type | End-Users ($ Million)
Airway Management Devices Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Airway Management Devices Industry Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Airway Management Devices Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For the Global Airway Management Devices Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Airway Management Devices Market: Impact Analysis
3.3. Market Opportunities
- 3.3.1. Opportunities For Global Airway Management Devices Market: Impact Analysis

4. Competitive Landscape

4.1. Competitive Dashboard - Airway Management Devices Market Revenue and Share by Manufacturers
Airway Management Devices Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Ambu A/S
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis (Subject to Data Availability)
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Fisher & Paykel Healthcare Ltd.
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis (Subject to Data Availability)
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Medtronic PLC
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis (Subject to Data Availability)
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. ICU Medical, Inc.
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis (Subject to Data Availability)
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Teleflex Inc.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis (Subject to Data Availability)
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Airway Management Devices Market Sales Analysis By Type ($ Million)

5.1. Supraglottic Airway Management Devices
5.2. Infraglottic Airway Management Devices
5.3. Resuscitators
5.4. Laryngoscopes
5.5. Others

6. Global Airway Management Devices Market Sales Analysis By End-Users ($ Million)

6.1. Hospitals and Clinics
6.2. Homecare

7. Regional Analysis

1.1. North American Airway Management Devices Market Sales Analysis - Type | End-Users | Country ($ Million)
Macroeconomic Factors for North America
- 1.1.1. United States
- 1.1.2. Canada
1.2. European Airway Management Devices Market Sales Analysis - Type | End-Users | Country ($ Million)
Macroeconomic Factors for Europe
- 1.2.1. UK
- 1.2.2. Germany
- 1.2.3. Italy
- 1.2.4. Spain
- 1.2.5. France
- 1.2.6. Russia
- 1.2.7. Rest of Europe
1.3. Asia-Pacific Airway Management Devices Market Sales Analysis - Type | End-Users | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 1.3.1. China
- 1.3.2. Japan
- 1.3.3. South Korea
- 1.3.4. India
- 1.3.5. Australia & New Zealand
- 1.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
- 1.3.7. Rest of Asia-Pacific
1.4. Rest of the World Airway Management Devices Market Sales Analysis - Type | End-Users | Country ($ Million)
Macroeconomic Factors for the Rest of the World
- 1.4.1. Latin America
- 1.4.2. Middle East and Africa

8. Company Profiles

8.1. Ambu A/S
- 1.4.3. Quick Facts
- 1.4.4. Company Overview
- 1.4.5. Product Portfolio
- 1.4.6. Business Strategies
8.2. Armstrong Medical Ltd.
- 8.2.1. Quick Facts
- 8.2.2. Company Overview
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategies
8.3. Becton, Dickinson and Co.
- 8.3.1. Quick Facts
- 8.3.2. Company Overview
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategies
8.4. Boston Scientific Corp.
- 8.4.1. Quick Facts
- 8.4.2. Company Overview
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategies
8.5. Cardinal Health Inc.
- 8.5.1. Quick Facts
- 8.5.2. Company Overview
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategies
8.6. Cook Group, Inc.
- 8.6.1. Quick Facts
- 8.6.2. Company Overview
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategies
8.7. Fisher & Paykel Healthcare Ltd.
- 8.7.1. Quick Facts
- 8.7.2. Company Overview
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategies
8.8. Flexicare Group Ltd.
- 8.8.1. Quick Facts
- 8.8.2. Company Overview
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategies
8.9. Fujifilm Holdings Corp.
- 8.9.1. Quick Facts
- 8.9.2. Company Overview
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategies
8.10. General Electric Co.
- 8.10.1. Quick Facts
- 8.10.2. Company Overview
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategies
8.11. ICU Medical, Inc.
- 8.11.1. Quick Facts
- 8.11.2. Company Overview
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategies
8.12. Intersurgical Ltd.
- 8.12.1. Quick Facts
- 8.12.2. Company Overview
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategies
8.13. Medtronic PLC
- 8.13.1. Quick Facts
- 8.13.2. Company Overview
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategies
8.14. Mercury Medical
- 8.14.1. Quick Facts
- 8.14.2. Company Overview
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategies
8.15. Olympus Corp.
- 8.15.1. Quick Facts
- 8.15.2. Company Overview
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategies
8.16. Richard Wolf GmbH
- 8.16.1. Quick Facts
- 8.16.2. Company Overview
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategies
8.17. Salter Labs Inc.
- 8.17.1. Quick Facts
- 8.17.2. Company Overview
- 8.17.3. Product Portfolio
- 8.17.4. Business Strategies
8.18. Stryker Corp.
- 8.18.1. Quick Facts
- 8.18.2. Company Overview
- 8.18.3. Product Portfolio
- 8.18.4. Business Strategies
8.19. Med Alliance Group, Inc.
- 8.19.1. Quick Facts
- 8.19.2. Company Overview
- 8.19.3. Product Portfolio
- 8.19.4. Business Strategies
8.20. Teleflex Inc.
- 8.20.1. Quick Facts
- 8.20.2. Company Overview
- 8.20.3. Product Portfolio
- 8.20.4. Business Strategies
8.21. Tuoren Medical Device India Pvt. Ltd.
- 8.21.1. Quick Facts
- 8.21.2. Company Overview
- 8.21.3. Product Portfolio
- 8.21.4. Business Strategies
8.22. Verathon Inc.
- 8.22.1. Quick Facts
- 8.22.2. Company Overview
- 8.22.3. Product Portfolio
- 8.22.4. Business Strategies
8.23. Vitalograph Ltd.
- 8.23.1. Quick Facts
- 8.23.2. Company Overview
- 8.23.3. Product Portfolio
- 8.23.4. Business Strategies
8.24. Vyaire Medical
- 8.24.1. Quick Facts
- 8.24.2. Company Overview
- 8.24.3. Product Portfolio
- 8.24.4. Business Strategies
8.25. Well Lead Medical Co. Ltd.
- 8.25.1. Quick Facts
- 8.25.2. Company Overview
- 8.25.3. Product Portfolio
- 8.25.4. Business Strategies
8.26. Xiamen Compower Medical Tech Co., Ltd.
- 8.26.1. Quick Facts
- 8.26.2. Company Overview
- 8.26.3. Product Portfolio
- 8.26.4. Business Strategies